Log in to save to my catalogue

Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1938603122

Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

About this item

Full title

Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

Publisher

Tokyo: Springer Japan

Journal title

International journal of hematology, 2017-11, Vol.106 (5), p.612-621

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

The effect of rituximab on primary central nervous system lymphoma (PCNSL) is controversial. We performed this meta-analysis to assess the efficacy of treatment with or without rituximab for PCNSL. We first conducted a search for qualified studies using PubMed, the Cochrane Library, and the Web of Science. The meta-analysis was conducted to compare...

Alternative Titles

Full title

Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1938603122

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1938603122

Other Identifiers

ISSN

0925-5710

E-ISSN

1865-3774

DOI

10.1007/s12185-017-2316-z

How to access this item